[United States Statutes at Large, Volume 130, 114th Congress, 2nd Session]
[From the U.S. Government Publishing Office, www.gpo.gov]


Public Law 114-154
114th Congress

An Act


 
To provide the Department of Justice with additional tools to target
extraterritorial drug trafficking activity, and for other
purposes. <>

Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled, <>
SECTION 1. SHORT TITLE.

This Act may be cited as the ``Transnational Drug Trafficking Act of
2015''.
SEC. 2. POSSESSION, MANUFACTURE OR DISTRIBUTION FOR PURPOSES OF
UNLAWFUL IMPORTATIONS.

Section 1009 of the Controlled Substances Import and Export Act (21
U.S.C. 959) is amended--
(1) by redesignating subsections (b) and (c) as subsections
(c) and (d), respectively; and
(2) in subsection (a), by striking ``It shall'' and all that
follows and inserting the following: ``It shall be unlawful for
any person to manufacture or distribute a controlled substance
in schedule I or II or flunitrazepam or a listed chemical
intending, knowing, or having reasonable cause to believe that
such substance or chemical will be unlawfully imported into the
United States or into waters within a distance of 12 miles of
the coast of the United States.

``(b) It shall be unlawful for any person to manufacture or
distribute a listed chemical--
``(1) intending or knowing that the listed chemical will be
used to manufacture a controlled substance; and
``(2) intending, knowing, or having reasonable cause to
believe that the controlled substance will be unlawfully
imported into the United States.''.
SEC. 3. TRAFFICKING IN COUNTERFEIT GOODS OR SERVICES.

Chapter 113 of title 18, United States Code, is amended--
(1) in section 2318(b)(2), by striking ``section 2320(e)''
and inserting ``section 2320(f)''; and
(2) in section 2320--
(A) in subsection (a), by striking paragraph (4) and
inserting the following:
``(4) traffics in a drug and knowingly uses a counterfeit
mark on or in connection with such drug,'';
(B) in subsection (b)(3), in the matter preceding
subparagraph (A), by striking ``counterfeit drug'' and
inserting ``drug that uses a counterfeit mark on or in
connection with the drug''; and

[[Page 388]]

(C) in subsection (f), by striking paragraph (6) and
inserting the following:
``(6) <>  the term `drug' means a drug,
as defined in section 201 of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 321).''.

Approved May 16, 2016.

LEGISLATIVE HISTORY--S. 32 (H.R. 3380):
---------------------------------------------------------------------------

HOUSE REPORTS: No. 114-603, Pt. 1 (Comm. on the Judiciary) accompanying
H.R. 3380.
CONGRESSIONAL RECORD:
Vol. 161 (2015):
Oct. 7, considered and passed
Senate.
Vol. 162 (2016):
May 10, considered and passed House.